3 курс / Патологическая физиология / Анафилактические_реакции_при_анестезии_и_интенсивной_терапии_Леви

quency of atopy and allergy ft* an anaesthetic patient population.— Brit. J. Anaesth., 1978, 50, 793—708.

93.Dutcher J. P., Aisner J., Hogge D. E., Schiffer C. A. Donor reacti­ on to hydroxyethyl starch during granulocytapheresis.— Transfu­ sion, 1984, 24, 66—67.

94.Eggleston P. A. In: Current Therapy. Anaphylaxis and serum sicknes/Ed. H. F. Conn.— Philadelphia: Saunders, 1983, 573.

96.Eisenberg M. S., Copass M. Қ. Emergency Medical Therapy.— Philadelphia: Saunders, 1982, 563.

97.Ellison N. et al. Bradykinin, plasma protein fraction, and hypoten­

100.Eyre P., Lewis A. /. Production of kinins in bovine anaphylactic shock.— Brit. J. Pharmacol., 1972, 44, 311—313.

101.Ezra D., Boyd L. M.t Feuerstein G., Goldstein R. E. Coronary

constriction by leukotriene C4, D* in the intact pig heart.— Amer.

J. Cardiol., 1983, 51, 1451—1454.

102.Fabian I., Aronson M. Polycations as possible substitutes for pro­

tamine in heparin neutralization.— Thrombosis Res., 1980, 37, 237.

103.Fadali M. A., Papacostas C. A.t Duke J. J., Ledbetter М., Osbakken M. Cardiovascular depressant effect of protamine sulphate: experimental study and clinical implications.— Thorax, 1976, 31, 320—323.

104.Fahmy N. R S u n d e r N.t Soter N. A. Role of histamine in the he­ modynamic and plasma catecholamine responses to morphine.— Clin. Pharmacol. Ther., 1983, 33, 615—620.

105.Fairman R. P., Morrow C., Glauser F. L. Methylmethacrylate indu­

ces pulmonary hypertension and increases lung vascular perme­ ability in sheep.— Amer. Rev. resp. Dis., 1984, 130, 92—95.

106.Falk R. H. Allergy to diazepam.— Brit. Med. J., 1977, 2, 287.

107.Faraj B. A., Gottlieb G. R., Camp V. M.t Kutner М., Lolies P. De­

110.Felbo М., Jensen Қ. G. Death in childbirth following transfusion of leukocyte incompatible blood.— Acta Haemat., 1962, 27, 113— 119.

111.Feldberg W., Paton W. D. Release of histamine from skin and muscle in the cat by opium alkaloids and other histamine libera­ tors.— J. Physiol., 1951, 114, 490—509.

112.Fiedel A., Rent R., Myhrman R., Gewurz H. Complement activation by interaction of polyanions and polycations.— Immunology, 1976.

113.Findlay S. R.t Dvorak A. М., Kagey-Sobotka A., Lichtenstein L. M.

Hyperosmolar triggering of histamine release from human baso-. phils.— J. Clin. Invest., 1981, 67r 1604—1613.

161

114. Fiser W. P., Fewell J. £ , Hill D. E., Barnes R. W.t Read R. C. Car­ diovascular effects of protamine sulfate are dependent on the pre­ sence and type of circulating heparin.— J. thorac. cardiovasc. Surg, 1985, 89, 63—70.

115. Fisher Af. Af. The epidemiology of anaesthetic anaphylactoid reac­ tions in Australasia.— Klin. Wschr, 1982, 60, 1017—1020.

116.Fisher Af. Af. Severe histamine mediated reactions to althesin.— Anaesth. Intensive Care, 1976, 4, 33—35.

117.Fisher Af. Af. Blood volume replacement in acute anaphylactic car­ diovascular collapse related to anaesthesia.— Brit. J. Anaesth, 1977, 49, 1023—1026.

118.Fisher Af. Af. Intradermal testing in the diagnosis of acute anaphy­

119.Fisher Af. Af. Reaginic antibodies to drugs used in anesthesia.— Anesthesiology, 1980, 52, 318—320.

120.Fisher M. Af. The diagnosis of acute anaphylactoid reactions to

124.Fisher Af. Af, Roffe D. J. Allergy, atopy and IgE.— Anaesthesia, 1984, 39, 213—217.

125.Fisher M. Af, Teisnner B., Charlesworth J. Significance of sequestial changes in serum complement levels during acute anaphylac­ toid reactions.— Crit. Care Med, 1984, 12, 351—353.

126.Ford R. Af. Management of acute allergic disease including anaphy­ laxis.— Med. J. Aust, 1977, 1, 222—223.

127.Frick O. L. In: Basic and Clinical Immunology, 14th ed. Immediate hypersensitivity/Eds. D. P. Stites, J. D. Stobo, H. H. Fudenberg,

J.V. Wells.— Los Angeles: Lange Medical Publications, 1982.

128.Furhoff A. K. Anaphylactoid reactions to dextran — a report of 133 cases.— Acta Anaesthesiol. Scand, 1977, 21, 161—167.

129.Gell P. G. H., Coombs R. R. Л. (eds.) Clinical aspects of Immu­

nology, 3rd ed.— Oxford: Blackwell Scientific Publications, 1975. 130. Gill С Michaelides P. L. Dental drugs and anaphylactoid reacti­

ons: report of a case.— Oral Surg, 1980, 50, 30—32.

131. Ginsburg R.t Bristow Af. R., Kantrowitz N.t Bairn F. S., Harri­ son D. C. Histamine provocation of clinical coronary artery spasm. Amer. Heart. J , 1981, 102, 819—822.

132.Ginsburg R , Bristow Af. R.t Stinson, E. В , Harrison D. C. Hista­ mine receptors in the human heart.— Life Sci, 1980, 26, 2245—2249.

133.Gleichmann H., Breininger J. Over 95% sensitization against allo­ geneic leukocytes following dingle massive blood transfusion.— Vox Sang, 1975, 28, 66—73.

134.Glovsky Af. Af. Anaphylatoxin-induced histamine release with hu­ man leukocytes. Studies of S3a leukocyte binding and histamine release.— J. clin. Invest, 1979, 64, 804—811.

135.Goetzl E. /. Mediators of immediate hypersensitivity derived from arachidonic acid.— N. Eugl. J. Med, 1980, 303, 822—925.

162

136. Goetzl E. J. Asthma: new mediators and old problems.— N. Engl.

J. Med., 1984, 311, 252—253.

137.Goldberg M. Systemic reactions to intravascular contrast media.— Anesthesiology, 1984, 60, 46—56.

138.Goldenberg М., Pines K. L., Baldwin E. F. The hemodynamic res­

ponse of man to norepinephrine and epinephrine and its relation to the problem of hypertension.— Amer. J. Med., 1948, 5, 792—806.

139.Goldfinger D.t Lowe C. Prevention of adverse reactions to blood transfusion by administration of saline-washed red blood cells.— Transfusion, 1981, 21, 277—280.

140.Gonzales G. D., Lewis A. J.t eds. Modern Drug Encyclopedia and

Therapeutic Index.— New York: Yorke Medical Books, 1981, 339.

141.Grammer L. C., Patterson R. Proteins: Chymopapain and insulin.— J. Allergy Clin. Immunol., 1984, 74, 635—640.

142.Grammer L. C. IgE against ethylene oxide-altered human serum albumin in patients who have had acute dialysis reactions.— J. Al­ lergy Clin. Immunol., 1984, 74, 544—546.

143.Grant J. A. Anaphylactic reactions to protamine in insulindependent diabetics during cardiovascular surgery.— Anesthesio­

logy, 1983, 59, A74.

144.Grant J. A., Dupree E., Goldman A. S., Schultz D. R.t Jackson A. L.

Coplement-mediated release of histamine from human leukocytes.— J. Immunol., 1975, 114, 1101—1106.

145.Grant /. A., Settle L., Whorton W. B., Dupree E. Complement-me­ diated release of histamine from human basophils.— J. Immunol., 1976, 117, 450—456.

146.Green G. R., Rosenblum A. Report of the penicillin study group, American Academy of Allergy.— J. Allergy clin. Immunol., 1971.

147.Greenberger P. A. Contrast media reactions.— J. Allergy Clin. Im­ munol., 1984, 74, 600—605.

148.Greenberger P., Patterson R K e lly J., Stevenson D. D.t Simon R., Lieberman P. Administration of radiographic contrast media in high risk patients.— Invest. Radiol., 1980, 15, 540—543.

149.Greenberger P., Patterson R., Simon R. Pretreatment of high-risk

patients requiring radiographic contrast media studies.— J. Allergy Clin. Immunol., 1981, 67, 185—187.

150.Greenberger P. A., Patterson R.t Tapio С. M. Prophylaxis against repeated radiocontrast media reactions in 857 cases.— Arch, intern. Med., 1985, 145, 2197—2200.

151.Hagedorn H. C., Jensen B. N., Krarup N. B. et al. Protamine insulinate.— J. A. M. A., 1936, 106, 177—180.

152.Halevy S ., Altura В. M. Hiand H2-histamine receptor antagonists against traumatic shock.— Proc. Soc. exp. Bio. Med., 1977.

153.Halevy S., Altura В. Т., Altura В. M. Pathophysiological basis for the use of steroids in the treatment of shock and trauma.— Klin. Wschr., 1982, 60, 1021— 1030.

154.Hammerschmidt D. E. Of lungs and leuKOcytes.— J. A. M. A., 1980.

155.Hammerschmidt D. E., Harris P. D., Wayland J. H„ Craddock P. R.t Jacob H. S. Complement-induced granulocyte aggregation in vi­ vo.— Amer. J. Pathol., 1981, 102, 146—150.

156.Hammerschmidt D. E J a c o b H . 5. In: Advances in internal medi­ cine. Adverse pulmonary reactions to transfusion/Ed. G. H. Stollerman.— Chicago: Year Book Medical Publishers, 1982, 511—530.

157.Hammerschmidt D. E. et al. Association of complement activation and elevated plasma-Сба with adult respiratory distress syndro­ me.— Lancet, 1980, 1, 947—949.

163

158.Hammerschmidt D. E.t White J. G., Craddock P. R., Jacob H. S.

Corticosteroids inhibit complement-induced granulocyte aggregati­ on.— J. clin. Invest., 1979, 63, 798—803.

159.Hanashiro P. Қ Weil М. H. Anaphylactic shock in man.— Arch, intern. Med., 1967, 119, 129—140.

160.Hanna C. J., Bach М. K., Pare P. D., Schellenberg R. R. Slowreacting substances (leukotrienes) contrast human airway and pul­

monary vascular smooth muscle in vitro.— Nature, 1981, 290.

161.Hardy С. C., Robinson С., Tattersfield A. E.t Hoigate S. T. The bronchoconstriction effect of inhaled prostaglandin D2 in normal and asthmatic men.— N. Engl. J. Med., 1984, 311, 209—213.

162.Harle D. G., Baldo B. A ., Fisher М. M. Detection of IgE antibodies

164.Harvey S. C. In: Remington’s pharmaceutical sciences. Sympatho­ mimetic drugs/Ed. A. Osol.— Easton: Mack Publishing, 1980, 815.

165.Heinrich D., Eckhardt С. М., Stier W. The specificity of leukocyte and platelet alloantibodies in sera of patients with nonhemolytic transfusion reactions.— Vox Sang., 1973, 25, 442—446.

166.Hellema H. W. J., Rumke P. Sperm autoantibodies as a consequ­ ence of vasectomy.— Clin. exp. Immunol., 1978, 31, 18—29.

167.Hermens J. M E b e r ts J. М., Hanifin J. М., Hirschmon C. A. Com­ parison of histamine release in human skin mast cells by morphine,

171.Hong S. L., Levine L. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticostero­ ids.— Proc. nat. Acad. Sci., 1976, 73, 1730—1734.

172.Hock W. A., Siraganian R. P. Influence of anions, cations and osmolarity on IgE-mediated histamine release from human baso­ phils.— Immunology, 1981, 43, 723—731.

173.Horak A., Raine R., Opie L. H., Lloyd E. A. Severe myocardial

ischemia induced by intravenous adrenalin^.— Brit. Med. J., 1983.

174.Horrow J. C. Protamine: A review of its toxicity.— Anesth. Analg., 1985, 64, 348—361.

175.Hotchkiss R. S., Wilson R. S. Mechanical Ventilatory Support — Surg. Clin. N. Amer., 1983, 63, 417—438.

176.Huestis D. W. Anti-IgA in blood donors.— Transfusion, 1976, 16, 289—290.

177. Hurst J. W., ed. The Heart, 5th edition.— New York: McGrawHill, 1983.

178.Huttel M. S., Schou Olesen A., Stoffersen M. Complement media­ ted solvent reactions to diazepam with cremophor as solvent (Stesolid MR).— Brit. Anaesth. J., 1980, 52, 77—79.

179.Idsoe O., Guthe Т., Willcox R. R., DeWeck A. L. Nature and extent

164

180.Incaudo G. et al. Administraton of local anesthetics to patients with a history of prior adverse reaction — J. Allergy Clin. Immu­

nol., 1978, 61, 339—345.

181.Ishizaka T. Analysis of triggering events in mast cells for immuno­ globulin E-mediated histamine release.— J. Allergy Clin. Immunol., 1981, 67, 90—96.

182.Isles A. F., MacLeod S. M L e v iso n H. Theophylline: New thoughts about an old drug.— Chest, 1982, 82, 495—545.

183.Jacob H. S., Craddock P. R., Hammerschmidt D. E., Moldow C. F.

Complement-induced granulocyte aggregation. An unsuspected

mechanism of disease.— N. Eugl. J. Med., 1980, 302, 789—794.

184. James L. P., Austen K. F. Fatal systemic anaphylaxis in man.—

N.Engl. J. Med., 1964, 270, 597—603.

185.Jaques L. B. A study of the toxicity of the protamine, salmine.— Brit. J. Pharmacol., 1949, 4, 135—144.

186.Jasani B., Kreil G., Mackler B. F., Stanworth D. F. Further studies on the structural requirements for polypeptide-mediated histamine release from rat mast cells.— Biochem. J., 1979, 181, 623—632.

187.Jick H. Adverse drug reactions: The magnitude of the problem.—

J.Allergy clin. Immunol., 1984, 74, 555—557.

188.Johansson S. G. O. In vitro diagnosis of reagin-mediated allergic diseases.— Allergy, 1978, 33, 292—298.

189.Johnson A. R., Erdos E. G. Release of histamine from mast cells by vasoactive, peptides.— Proc. Soc. exp. Biol. Med., 1973, 142.

190.Jones H. М., Matthews N., Vaughan R. S., Stark J. M. Cardiopul­

monary bypass and complement activation — Anaesthesia, 1982.

191.Just-Viera J. O., Fischer C. R., Gago O., Morris J. D. Acute reaction to protamine.— Amer. Surg., 1984, 50, 52—60.

192.Kahan B. D.t Wideman C. A., Flechner S., Van Buren С. T. Ana­ phylactic reaction to intravenous cyclosporine.— Lancet, 1984, 1, 52.

193.Kaliner М., Shelhamer J. H., Ottesen E. A. Effects of infused hista­ mine.— J. Allergy clin. Immunol., 1982, 69, 283—289.

194.Kaliner M., Sigler R., Summers R., Shelhamer J. H. Effects of in­

fused histamine.— J. Allergy clin. Immunol., 1981, 68, 365—371. 195. Kallos T. Impaired arterial oxygenation associated with use of bone cement in the femoral shaft.— Anesthesiology, 1975, 42, 210—216.

196.Kalsner S., Richards R. Coronary arteries of cardiac patients are hyperreactive and contain stores of amines.— Science, 1984, 223.

197.Kaplan A. P.t Austen K. F. Activation and control mechanisms of Hageman factor-dependent pathways of coagulation, fibrinolysis, and kinin generation and their contribution to the inflammatory process.— J. Allergy clin. Immunol., 1975, 56, 491—506.

198.Kazimierczak W., Diamant B. Mechanisms of histamine release in anaphylactic and anaphylactoid reactions.— Progr. Allergy, 1978.

199.Kelly J. F., Patterson R. Anaphylaxis. Course, mechanisms and treatment.— J. A. M. A., 1974, 227, 1431—1436.

200.Kelly J. F. et al. Radiographic contrast media studies in high risk

patients.— J. Allergy clin, Immunol., 1978, 62, 181—184.

201.Kern R. A., Langner P. H. Jr. Protamine and allergy — J. A. M. A., 1938, 113, 198—200.

202.Kernoff P. B. A., Durrant I. J., Rizza C. R., Wright F. W. Severe allergic pulmonary oedema after plasma transfusion.— Brit. J. Haematol., 1972, 23, 777—781.

203.Khandelwal J. K., Hough L. B., Green J. P. Histamine and some

165

207.Kolstinen J. Selective IgA deficiency in blood donors.— Vox Sang., 1975, 29, 192—202.

208.Kolstinen J., Sarna A. Immunologic abnormalities in the sera of IgA deficient blood donors.— Vox. Sang., 1975, 29, 203—213.

209.Kraft D., de Week A. L., Hundgaard H.t eds. Allergic Reactions to Drugs.— Berlin: Springer-Verlag, 1983.

210.Kravis Т. C. In: Emergency medicine: a comprehensive review. Ob­ structive lung diseases/Eds. Т. C. Kravis, C. G. Warned.— Rock» ville M. D.: Aspen Systems Corp., 1983, 838.

211. LaForest M M o r e D F is h e r M. Predisposing factors in anaphy­ lactoid reactions to anaesthetic drugs in an Australian populati­ on.— Anaesth. Intens. Care, 1980, 8, 454—459.

212.Lagunoff D.t Martin T. W., Read G. Agents that release histamine from mast cells — Ann., Rev. Psarmacol., 1983, 23, 331—351.

213.Lakin J. D., Blocker T. Strong D. М., Yocum M. W. Anaphylaxis

218.Laser E. C.t Lang J. H., Lyon S. G., Hamblin A . E. Changes in complement and coagulation factors in a patient suffering a severe

anaphylactoid reaction to injected contrast media: Some conside­ rations of pathogenesis.— Invest. Radiol., 1980, 15 (suppl.), S6— 12.

222.Laxenaire М. C., Moneret-Vautrin D., Vervloet D. The French expe­ rience of anaphylactoid reactions.— Int. Anesthesiol. Clin., 1985, 23.

223.Laxenaire M. C.t Moneret-Vautrin D. A., Watkins J. Diagnosis of

225.Leikola J., Koistinen J., Lehtinen М., Virolainen M. IgA-induced anaphylactic transfusion reactions.— Blood, 1973, 42, 111—119.

226.Levy /. H. In: Refresher course in anesthesiology, vol. 13./Ed.

P.Barash, 1985, 129— 141.

227.Levy J. H. In. Chemonucleolysis anaphylaxis: mechanisms of action and strategies for treatment under general anesthesia, 21—34./Ed. Roizen.— Chicago: Smith Laboratories, 1983.

166

227a. Levy J. H. Anaphylactic/anaphylactoid reactions during cardiac surgery. Abstract, 1986 Society of Cardiovascular Anesthesiologists, Annual Meeting.

228. Levy /. H. Intravenous epinephrine therapy in anaphylaxis.—

J. A. M. A., 1983, 249, 3173.

229.Levy J. H. Anaphylaxis to chymopapain following antihistamine pretreatment.— Anesth. Analg., 1985, 64, 190.

230.Levy J. H., Rockoff M. R. Anaphylaxis to meperidine.— Anesth. Analg., 1982, 61, 301—303.

230b. Levy J. H., Roizeti M. F., Morris J. M. Anaphylactic and anaphy­ lactoid reactions.— Spine, 1986, 11, 282—291.

231.Lewis R. A., Austen K. F. The biologically active leukotrienes: bio­ syntheses, metabolism, receptors, functions, and pharmacology.—

J. Clin. Invest., 1984, 73, 889—902.

232.Liberman P., Siegle R. L., Taylor W. W. Jr. Anaphylactoid reacti­ ons to iodinated contrast media.— J. Allergy clin. Immunol., 1978.

233.Lichtenstein L. M. In: Cecil: textbook of medicine. Anaphylaxis/ Eds. J. .B Wyngarden, L. H. Smith.— Philadelphia: Saunders, 1982.

234.Ljungstroem Қ. G., Renck H.t Hedin H., Richter W., Rosenberg B.

Prevention of dextran induced anaphylactic reactions by hapten inhibition.— Acta chir. scand., 1983, 149, 341—348.

235.Lockey R. F., Fox R. W. Allergic emergencies.— Hosp. Med., 1979.

236.Lorenz W., Doenicke A., Schoning B.t Neugebauer E. In: Adverse reactions of anaesthetic drugs/Ed. J. A. Thornton — Amsterdam:

Elsevier/North Holland Biomedical Press, 1981, 169—238.

237.Lowenstein E., Hallowell P., Levine F. H., Daggett W. М., Aus­ ten W. G., Laver М. B. Cardiovascular response to large doses of morphine in man.— N. Engl. J. Med., 1969, 281, 1389— 1394.

238.Lowenstein E.t Johnston W. E., Lappas D. G. et al. Catastrophic pulmonary hypertension associated with protamine reversal of he­ parin.— Anesthesiology, 1983, 59, 470—473.

239.Loyd J. E., Newman J. H., Brigham K. L. Permeability pulmonary edema. Diagnosis and management.— Arch, intern. Med., 1984, 144.

240.Majno G., Palade G. E. Studies on inflammation. I. The effect of histamine and serotonin on vascular permeability: an electron mic­ roscopic study.— J. Biophys. Biochem. Cytol., 1961, 11, 571—672.

241.Majno G., Gilmore V., Leventhal M. The effect of histamine and serotonin on the mechanism of vascular leukage caused by hista­

mine-type mediators.— Circulat. Res., 1967, 21, 833—855,

•242. Majno G., Shea S. M.t Leventhal M. Endothelial contraction indu­ ced by histamine-type mediators.— J. Cell Biol., 1969, 42, 647—672.

243.Mantz J. M. et al. Le choc anaphylactique.— Rev. Med. Intern (Fr.), 1982, 3, 331—338.

244.Mason J. W., Kleeburg U., Dolan P., Colman R. W. Plasma kallikrein and Hageman factor in gram-negative bacteremia.— Ann. In­ tern. Med., 1970, 73, 545—551.

245.MathS A. A., Hedqvist P ., Strandberg K., Leslie C. A. Aspects of

prostaglandin function in the lung.— N. Engl. J. Med., 1977, 296.

246.Mathieu A., Goudsouzian N.t Snider М. T. Reaction to ketamine: anaphylactoid or anaphylactic.— Brit. J. Anaesth., 1975, 47, 624.

247.Matthay R. A., Berger H. Loke J., Gottschalk A., Zoret B. L.

Effects of aminophylline upon right and left ventricular performan­ ce in chronic obstructive pulmonary disease.— Amer. J. Med., 1978.

167

248.McIntosh F. С., Paton W._ D. M. The liberation of histamine by certain organic bases.— J. Physiol., 1949, 109, 190—219.

249.Meier H. L., Kaplan A. P., Lichtenstein L. M.t Revak S., Cochra­

ne C. G„ Newball H. H. Anaphylactic release of a prekallikrein ac­ tivator from human lung in vitro.— J. clin. Invest., 1983, 72, 574.

250.Metcalf D. D. Effector cell heterogenecity in immediate hypersensi­ tivity reactions.— Clin. Rev. Allergy, 1982, 1, 311—325.

251.Michaels J. A., Barash P. G. Hemodynamic changes during prota­ mine administration.— Anesth. Analg., 1983, 62, 831—835.

252.Michelassi F. et al. Leukotriene D*: A Potent coronary artery vaso­ constrictor associated with impaired ventricular contraction.— Sci­

254.Mikhail G. R., Miller-Milinska A. Mast cell population in human skin.— J. Invest. Dermatol., 1964, 43, 249—254.

255.Miller R., Tausk H. C. Anaphylactoid reaction to vancomycin du­ ring anesthesia. A case report.— Anesth. Analg., 1977, 56, 870—872.

256.Milne B., Rogers K., Cervenko F. The maemodynamic effects of intraaortic versus intravenous administration of protamine for re­ versal of heparin in man.— Canad. Anaesth. Soc. J., 1983, 30, 347.

257.Milner L. V., Butcher K. Transfusion reactions reported after trans­

fusion of red blood cells and of whole blood.— Transfusion, 1978.

258.Mitchell E. B., Askenase P. W. Basophils in human disease.— Clin. Rev. Allergy, 1983, 1, 427—448.

259.Moneret-Vautrin D. A., Mouton C., Widmer S. Anaphylaxie atnx myorelaxants — Ann. Fr. Anesth. Reanim., 1985, 4.

260.Moorthy S. S., Pond W., Rowland R. G. Severe circulatory shock

Lowenstein E. Acute pulmonary sequestration of white blood cells produced by I. V. bolus of protamine after cardiopulmonary by­ pass.— Anesthesiology, 1984, 61, A49.

262.Morrison D. C., Roser J. F., Cochrane C. G., Henson P. M. Two distinct mechanisms for the initiation of mast cell degranulation.— Int. Arch. Allergy, 1975, 49, 172—178.

263.Moss J., Fahmy N. R., Sunder N., Beaven M. A. Hormonal and hemodynamic profile of an anaphylactic reaction in man.— Circu­ lation, 1981, 63, 210—213.

264.Moss J., Philbin D. M., Rosow С. E., Basta S. Gelb C., Savarese J. J. Histamine release by neuromuscular blocking agents in man.— Klin. Wschr., 1982, 60, 891—895.

265. Moss Rosow C. W., Savarese J. J., Philbin D. М., Kniffen K. J.

Role of histamine in the hypotensive action of d-tubocurarine in humans.— Anaesthesiology, 1981, 55, 19—25.

266.Miiller-Eberhard H. J. Chemistry and function of the complement system.— Hosp. Pract., 1977, 12; 33—43.

267.Murano G. The «Hageman» connection: Interrelationships of blood coagulation, fibro (geno)ysis, kinin generation, and complement

activation.— Amer. J. Hematol., 1978, 4, 409—417.

268. Nagle J. E.t Fuscaldo J. Т., Fireman D. Paraben allergy.—

J. A. M. A., 1977, 237, 1594— 1595.

269.Newfield P., Roizen M. F. Hazards of rapid administration of van­ comycin— Ann. intern. Med., 1979, 91, 581.

168

270.Nicolas F., Villers D., Blatiloeil Y. Hemodynamic patterns in anaphylactic shock woth cardiac arrest.— Crit. Care Med., 1984, 12.

271.Nordstrom L., Fletcher R., Pavek K. Shock of anaphylactoid type induced by protamine. Acta anaesthesiol. scand., 1978.

272.Obeid A. I. et al. Fluid therapy in severe systemic reaction to ra­ diopaque. dye.— Ann. intern. Med., 1975, 83, 317—320.

273.O'Connor P. C., Erskine J. G., Pringle Т. H. Pulmonary oedema

after transfusion with fresh frozen plasma.— Brit. Med. J., 1981.

274.Oertel T. Bee-sting anaphylaxis: the use of military antishock trou­ sers.— Ann. emerg. Med., 1984, 13, 6, 459—461.

275.O’Flaherty /. Т., Wykle R. L. Biology and biochemistry of plateletactivating factor.— Clin. Rev. Allergy, 1983, 1, 353—367.

276. Okuno T. Anti-penicillin antibodies in transfused blood.—

J.A. M. A., 1971, 218, 95.

277.Olinger G. N., Becker R. М., Bonchek L. I. Noncardiac pulmonary edema and peripheral vascular collapse following cardiopulmonary hypass. Rare protamine reaction? — Ann. thorac. Surg., 1980, 19.

278.Orange R. P., Austen W. G., Austen K. F. Immunological release of histamine and slow-reacting substance of anaphylaxis from hu­ man lung.— J. Exp. Med., 1971, 134, 136s—148s.

279.Orange R. P., Donsky G. /. In: Allergy: principles and practice Anaphylaxis/Eds. E. Middleton, С. E. Reed, E. F. Ellis.— St. Louis: Mosby, 1978, 563.

280.Oswalt С. E.t Gales G. A., Holmstrom F. M. Pulmonary edema as a complication of acute airway obstruction.— J. A. M. A., 1977, 238.

281.Ottensmeyer E. P., Whitting R. F., Korn A. P. Three-dimensional

282.Owen D. A. A.t Harvey C. A., Boyce M. J. Effects of histamine on the circulatory system.— Klin. Wschr., 1982, 60, 972—977.

283.Patterson R. Early recognition of allergic reactions to new drugs.— J. Allergy Clin. Immunol., 1984, 74, 641—642.

284.Park w., Balinget P., Kenmore P., Macnamara Т. E. Changes in arterial oxygen tension during total hip replacement.— Anesthesio­ logy, 1973, 39, 642—646.

285.Parker C. W. Drug allergy.— N. Engl. J. Med., 1975, 292, 511—514.

286.Parker C. W. In: Leukotrienes and other lipoxygenase products/Eds. B. Samuelsson, R. Paoletti.— New York, Raven Press: 1982, 115— 126.

287.Patkar S. A., Diamant B. Mechanism of histamine release from rat peritoneal mast cells.— Klin. Wschr., 1982, 60, 948—953.

288.Patterson R.f Anderson J. Allergic reactions to drugs and biologic agents.— J. A. M. A., 1982, 248, 2637—2645.

289.Pavek K., Wegmann A., Nordstrom L., Schwander D. Cardiovascu­ lar and respiratory mechanisms in anaphylactic and anaphylactoid

shock reactions.— Klin. Wschr., 1982, 60, 941—947.

290.Payne R. The development and persistence of leukoagglutinins in parous women.— Blood, 1962, 19, 411—424.

291.Pearce F%L. Functional heterogeneity of mast cells from different species and tissues — Klin. Wschr., 1982, 60, 954—957.

292.Patz L. D. Immuologic reactions df human to cephalosporins.—

kose mit positivem Hauttest auf Fentanyl und Alloferin.— Anaesthesist., 1981, 30, 400—404.

169

mine antagonists with morphine anesthesia: A double-blind study.— Anesthesiology, 1981, 55, 292—296.

295.Phillips H., Cole P., Lettin A. Cardiovascular effects of implanted acrylic bone cement.— Brit. Med. J., 1971, 3, 460—461.

296.Pineda A. A., Taswell H. F.f Brzica S. M. Jr. Delayed hemolytic transfusion reaction. An immunologic hazard of blood transfusi­

on.— Transfusion, 1978, 18, 1—7.

297.Piper P. J. Release of active substances during anaphylaxis.— Agents Actions, 1976, 6, 547—550.

298.Plaut M. Histamine, HI and H2 antihistamines, and immediate

hypersensitivity reactions.— J. Allergy clin. Immunol., 1979, 63.

299.Popovsky M. A., Abel M. D., Moore S. B. Transfusion-related acu­ te lung injury associated with passive transfer of antileukocyte antibodies.— Amer. Rev. resp. Dis., 1983, 128, 185—189.

300.Portier М. М., Richet C. De l’action anaphylactique de certains venins.— C. R. Soc. Biol., 1902, 54, 170—172.

301.Powell J. R.t Brodtj J. M. Participation of Hi and H2 histamine receptors in physiological vasodilator responses.— Amer. J. Phy-, siol., 1976, 231, 1002—1009.

302.Pretty H. M.t Fudenberg H. H., Perkins H. A., Gerbode F. Anti­ gamma globulin antibodies after open heart surgery.— Blood, 1968.

303.Radermacker М., Gustin M. An in vivo demonstration of the antianaphylactic effect of terbutaline — Clin. Allergy, 1981, 11, 79—86.

304.Radford S. G.f Lockyer J. A., Sihpson P. J. Immunological aspects of adverse reactions to Althesin.— Brit* J. Anaesth., 1982, 54.

305.Ratnoff O. D., Nossel H. L. Wasp sting anaphylaxis.— Blood, 1983.

306.Redd W. P., Chick T. W., Jutila K., Butler C., Goldblum S. Pulmo-, nary leukostasis in fatal human pneumococcal bacteremia without pneumonia.— Amer. Rev. resp. Dis., 1984, 130, 1184—1187.

307.Reinhardt D.t Borchard V. HI receptor antagonists: comparative pharmacology and clinical use.— Klin. Wschr., 1982, 60, 983—990.

308.Rent R., Ertel N., Eisenstein R., Gewurz H. Complement activa­ tion by interaction of polyanions and polycations: 1. Heparin-pro-,

tamine induced consumption of complement.— J. Immunol., 1975.

309.Revenas B. Anaphylactic shock in the monkey: early circulatory response in aggregate anaphylaxis.— Uppsala, 1979.

310.Revenas B., Smedegard G. Aggregate anaphylaxis in the monkey:

attentuation of the pulmonary response by pretreatment with indomethacin — Circ. Shock, 1981, 8, 21—29.

311.Revenas B., Smedegard G., Arforske. Anaphylactic shock in the monkey. Respiratory mechanics, acidbox status, and blood gases.—

313.Ring J., Stephan W., Brendel W. Anaphylactoid reactions to infu­ sions of plasma protein and human serum albumin.— Clin. Allergy, 1979, 9, 89—97.

314.Ring J. In vitro studies involving histamine and lysosomal enzyme release from human peripheral leukocytes with different human se­ rum albumin (HSA) preparations.— Int. Arch. Allergy, 1984, 74.

315.Ring J., Arroyave С. М., Fritzler M. J., Tan E. M. In vitro hista-. mine and serotonin release by radiographic contrast media in man.— J. Allergy Clin. Immunol., 1978, 61, 145.

316.Ring J., Seifert J., Messmerk, Brendel W. Anaphylactoid reactions

170